vs

Side-by-side financial comparison of Editas Medicine, Inc. (EDIT) and FREQUENCY ELECTRONICS INC (FEIM). Click either name above to swap in a different company.

Editas Medicine, Inc. is the larger business by last-quarter revenue ($24.7M vs $17.1M, roughly 1.4× FREQUENCY ELECTRONICS INC). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -22.7%, a 33.2% gap on every dollar of revenue. On growth, FREQUENCY ELECTRONICS INC posted the faster year-over-year revenue change (8.3% vs -19.2%). FREQUENCY ELECTRONICS INC produced more free cash flow last quarter ($-1.1M vs $-36.4M). Over the past eight quarters, Editas Medicine, Inc.'s revenue compounded faster (366.9% CAGR vs 11.8%).

Editas Medicine, Inc.,, is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.

EDIT vs FEIM — Head-to-Head

Bigger by revenue
EDIT
EDIT
1.4× larger
EDIT
$24.7M
$17.1M
FEIM
Growing faster (revenue YoY)
FEIM
FEIM
+27.4% gap
FEIM
8.3%
-19.2%
EDIT
Higher net margin
FEIM
FEIM
33.2% more per $
FEIM
10.5%
-22.7%
EDIT
More free cash flow
FEIM
FEIM
$35.3M more FCF
FEIM
$-1.1M
$-36.4M
EDIT
Faster 2-yr revenue CAGR
EDIT
EDIT
Annualised
EDIT
366.9%
11.8%
FEIM

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
EDIT
EDIT
FEIM
FEIM
Revenue
$24.7M
$17.1M
Net Profit
$-5.6M
$1.8M
Gross Margin
38.2%
Operating Margin
-31.3%
10.0%
Net Margin
-22.7%
10.5%
Revenue YoY
-19.2%
8.3%
Net Profit YoY
87.6%
-32.1%
EPS (diluted)
$0.03
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EDIT
EDIT
FEIM
FEIM
Q4 25
$24.7M
$17.1M
Q3 25
$7.5M
$13.8M
Q2 25
$3.6M
$20.0M
Q1 25
$4.7M
$18.9M
Q4 24
$30.6M
$15.8M
Q3 24
$61.0K
$15.1M
Q2 24
$513.0K
$15.6M
Q1 24
$1.1M
$13.7M
Net Profit
EDIT
EDIT
FEIM
FEIM
Q4 25
$-5.6M
$1.8M
Q3 25
$-25.1M
$634.0K
Q2 25
$-53.2M
$3.2M
Q1 25
$-76.1M
$15.4M
Q4 24
$-45.4M
$2.7M
Q3 24
$-62.1M
$2.4M
Q2 24
$-67.6M
$2.6M
Q1 24
$-62.0M
$130.0K
Gross Margin
EDIT
EDIT
FEIM
FEIM
Q4 25
38.2%
Q3 25
36.8%
Q2 25
37.5%
Q1 25
43.8%
Q4 24
48.2%
Q3 24
44.4%
Q2 24
40.3%
Q1 24
22.6%
Operating Margin
EDIT
EDIT
FEIM
FEIM
Q4 25
-31.3%
10.0%
Q3 25
-325.4%
2.6%
Q2 25
-1440.6%
16.4%
Q1 25
-1635.1%
18.3%
Q4 24
-152.2%
16.5%
Q3 24
-107649.2%
15.7%
Q2 24
-14016.2%
16.0%
Q1 24
-5902.3%
-3.4%
Net Margin
EDIT
EDIT
FEIM
FEIM
Q4 25
-22.7%
10.5%
Q3 25
-333.0%
4.6%
Q2 25
-1487.8%
16.0%
Q1 25
-1633.5%
81.4%
Q4 24
-148.3%
16.8%
Q3 24
-101870.5%
16.1%
Q2 24
-13178.8%
16.9%
Q1 24
-5458.1%
0.9%
EPS (diluted)
EDIT
EDIT
FEIM
FEIM
Q4 25
$0.03
$0.18
Q3 25
$-0.28
$0.07
Q2 25
$-0.63
$0.33
Q1 25
$-0.92
$1.60
Q4 24
$-0.55
$0.28
Q3 24
$-0.75
$0.25
Q2 24
$-0.82
$0.28
Q1 24
$-0.76
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EDIT
EDIT
FEIM
FEIM
Cash + ST InvestmentsLiquidity on hand
$146.6M
$3.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
$58.5M
Total Assets
$186.5M
$92.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EDIT
EDIT
FEIM
FEIM
Q4 25
$146.6M
$3.0M
Q3 25
$165.6M
$4.5M
Q2 25
$178.5M
$4.7M
Q1 25
$221.0M
$5.5M
Q4 24
$269.9M
$9.7M
Q3 24
$265.1M
$16.2M
Q2 24
$279.1M
$18.3M
Q1 24
$296.2M
$11.7M
Total Debt
EDIT
EDIT
FEIM
FEIM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$57.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
EDIT
EDIT
FEIM
FEIM
Q4 25
$27.3M
$58.5M
Q3 25
$13.5M
$56.3M
Q2 25
$19.2M
$55.6M
Q1 25
$62.4M
$51.8M
Q4 24
$134.3M
$36.2M
Q3 24
$175.6M
$33.2M
Q2 24
$232.0M
$39.8M
Q1 24
$294.4M
$36.7M
Total Assets
EDIT
EDIT
FEIM
FEIM
Q4 25
$186.5M
$92.3M
Q3 25
$201.8M
$93.2M
Q2 25
$210.6M
$93.7M
Q1 25
$263.7M
$86.4M
Q4 24
$341.6M
$77.8M
Q3 24
$327.6M
$84.3M
Q2 24
$384.8M
$83.3M
Q1 24
$440.3M
$77.7M
Debt / Equity
EDIT
EDIT
FEIM
FEIM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.43×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EDIT
EDIT
FEIM
FEIM
Operating Cash FlowLast quarter
$-36.4M
$-523.0K
Free Cash FlowOCF − Capex
$-36.4M
$-1.1M
FCF MarginFCF / Revenue
-147.3%
-6.6%
Capex IntensityCapex / Revenue
0.2%
3.6%
Cash ConversionOCF / Net Profit
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$-5.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EDIT
EDIT
FEIM
FEIM
Q4 25
$-36.4M
$-523.0K
Q3 25
$-30.8M
$1.2M
Q2 25
$-50.2M
$-155.0K
Q1 25
$-47.8M
$-3.6M
Q4 24
$-50.8M
$3.8M
Q3 24
$-52.6M
$-1.5M
Q2 24
$-57.1M
$7.5M
Q1 24
$-49.9M
$4.2M
Free Cash Flow
EDIT
EDIT
FEIM
FEIM
Q4 25
$-36.4M
$-1.1M
Q3 25
$-31.3M
$385.0K
Q2 25
$-786.0K
Q1 25
$-47.9M
$-4.0M
Q4 24
$-51.3M
$3.3M
Q3 24
$-55.5M
$-1.8M
Q2 24
$-60.6M
$6.7M
Q1 24
$-51.7M
$3.9M
FCF Margin
EDIT
EDIT
FEIM
FEIM
Q4 25
-147.3%
-6.6%
Q3 25
-414.6%
2.8%
Q2 25
-3.9%
Q1 25
-1028.6%
-20.9%
Q4 24
-167.6%
20.8%
Q3 24
-90998.4%
-11.8%
Q2 24
-11804.3%
42.8%
Q1 24
-4558.9%
28.4%
Capex Intensity
EDIT
EDIT
FEIM
FEIM
Q4 25
0.2%
3.6%
Q3 25
5.7%
5.6%
Q2 25
0.0%
3.2%
Q1 25
2.4%
1.7%
Q4 24
1.8%
3.3%
Q3 24
4788.5%
2.2%
Q2 24
681.1%
5.3%
Q1 24
164.8%
2.3%
Cash Conversion
EDIT
EDIT
FEIM
FEIM
Q4 25
-0.29×
Q3 25
1.83×
Q2 25
-0.05×
Q1 25
-0.24×
Q4 24
1.44×
Q3 24
-0.60×
Q2 24
2.85×
Q1 24
32.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EDIT
EDIT

Segment breakdown not available.

FEIM
FEIM

POC Revenue$14.8M86%
POT Revenue$2.3M13%

Related Comparisons